North American Psoriasis and Psoriatic Arthritis Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

The study provides strategic analysis of products available as well as products in pipeline for the treatment of Psoriasis and Psoriatic Arthritis markets. Patient forecasts along with physician perspective of the psoriatic markets has been provided. The study provides detailed revenue forecasts for existing as well as major products in development. Frost & Sullivan awards have been bestowed to emerging companies in this market.

Table of Contents

North American Psoriasis and Psoriatic Arthritis Markets, North American Psoriasis and Psoriatic Arthritis MarketsNorth American Psoriasis and Psoriatic Arthritis MarketsOverviewPatient ForecastsStrategic Product AnalysisPrescribing Patterns and TrendsPipeline and Competitor AnalysisMarket ForecastsFrost & Sullivan AwardsDecision Support DatabasesPsoriasis Prevalence - United StatesPsoriasis Prevalence - CanadaPsoriasis Drugs in Clinical TrialsBiotechnology CompaniesPopulation




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.